Understanding Essential Thrombocythemia (ET)

Essential Thrombocythemia (ET) is a rare chronic blood disorder that belongs to a group of conditions called myeloproliferative neoplasms (MPNs).

In ET, the bone marrow — the spongy tissue inside our bones that produces blood cells — creates too many platelets.

Platelets are the small, disc-shaped cells that help blood clot when you have a cut or injury. Normally, they prevent dangerous bleeding. But when there are too many platelets, or when platelets don’t function properly, two problems can arise:

• Clotting (thrombosis): Excess platelets can cause blood clots that may block arteries or veins.
• Bleeding: Even with high platelet counts, some people bleed more easily because platelets are not functioning correctly.

Common Symptoms That People Experience

Although ET is sometimes silent and picked up through routine blood tests, many people experience symptoms that affect daily life:

• Headaches or migraines (often persistent or sudden)
• Dizziness or lightheadedness
• Blurred vision, flashing lights, or blind spots
• Burning, tingling, or redness in hands and feet
• Unexplained bruising or nosebleeds
• Persistent fatigue that doesn’t improve with rest
• Abdominal discomfort (often due to an enlarged spleen)

These symptoms often feel disconnected at first, but they reflect underlying changes in circulation and blood regulation.

The Science Behind ET

Most cases of ET are linked to genetic mutations in blood-forming stem cells. The most common include:

• JAK2 mutation — found in around 60% of patients
• CALR mutation — present in approximately 20–25%
• MPL mutation — found in a smaller percentage

These mutations lead to abnormal cell signalling and uncontrolled platelet production.

Diagnosis typically involves:

• Blood tests (elevated platelet count above 450,000/µL)
• Bone marrow biopsy
• Genetic testing for JAK2, CALR, or MPL

Conventional Treatment Approaches

Treatment depends on individual risk factors:

• Low-dose aspirin to reduce clotting risk
• Medications to reduce platelet production (cytoreductive therapy)
• Lifestyle changes (blood pressure, cholesterol, smoking)

These treatments help manage ET but do not cure it.

What Is BioAcoustics?

Human BioAcoustics is an emerging field that studies how the human voice reflects internal biological states.

Every molecule, protein, and organ has a measurable frequency — a vibrational signature.

By analysing a short voice recording, it is possible to identify frequency imbalances that may relate to:

• Biochemical pathways
• Inflammatory processes
• Circulatory function
• Stress-related signalling

“Your voice is a holographic representation of your health. Every change in your body is mirrored in your vocal frequencies.”

The entire process is done remotely — voice recorded at home, analysed digitally, and personalised tones delivered online.

How BioAcoustics Can Relate to ET

Although ET is a genetic blood disorder, many of its symptoms are driven by broader regulatory systems in the body.

BioAcoustics may support:

• Platelet regulation pathways
• Vascular tone and circulation
• Inflammatory signalling
• Nervous system balance

“Sound is the body’s original language. When the right frequencies are applied, the body responds in kind.”

What a BioAcoustic Session Might Look Like

1. Voice recording (quick and done at home)
2. Frequency analysis using FFT
3. Personalised frequency playlist
4. Follow-up and adjustment

Final Thoughts

Essential Thrombocythemia requires proper medical supervision. However, complementary approaches like BioAcoustics may provide additional support by helping regulate internal communication systems and reduce symptom burden.

“Every symptom is a sound out of tune. By restoring harmony in frequency, we encourage harmony in health.”

Take the Next Step